We have studied the kinetics of oxalate-induced turbidity in fresh human urine and artificial urine. Assays are performed in 96-well plates, which allows many oxalate concentrations to be studied, repeatedly, in a short time. The metastable limit is defined in terms of the lowest oxalate concentration that gives a rate of change of attenuance significantly greater than the control. Interpretation of rates above this limit is based on ln/ln plots of initial rates against added oxalate concentration. This approach has a good theoretical basis, is well supported by our results and gives a turbidity rate index that is related to the product of the growth rate constant and a factor relating to the number and characteristics of the heteronuclei responsible for initiation of crystallization. This interpretation is posited upon the assumptions that second-order crystallization kinetics occur in unseeded urine when supersaturation exceeds the metastable limit and that aggregation during the initial phase of crystallization does not significantly contribute to changes in turbidity. Metastable limits of urine from healthy volunteers corresponded to a calcium oxalate supersaturation ratio of approx. 10. The turbidity rate index was higher in human urine than in artificial urine. The metastable limit, based on either oxalate concentration or supersaturation, for induction of calcium oxalate crystallization in normal human urine is higher than is likely to be found in normal subjects in vivo. The shape of the relationship between the metastable limit (based on oxalate concentration) and calcium concentration emphasizes the benefit of achieving a low urine calcium concentration. Comparison of the turbidity rate indices for human and artificial urine suggests that the role of nucleation promoters is more dominant than that of growth inhibitors.
INTRODUCTION
The incidence of kidney and ureteric stones in developed countries is high (lifetime expectancy is about 12 % for American men) [1] ; while this incidence has been increasing throughout the 1900s [1] , the age of onset is decreasing [2] . Recurrence rates are also high (14 % after 1 year, rising to 52 % after 10 years) [1] . Urolithiasis therefore imposes a significant burden on patients and health care finances. Most urinary stones are found in the upper tract, and the majority (about 80 %) contain calcium oxalate as their primary or secondary component. Calcium oxalate crystallization studies therefore play an important role in urolithiasis research and clinical management.
As might be expected, a number of different crystallization methods have been developed, some more suited to particular purposes than others. A frequently chosen approach is to allow the supersaturation to decay and to monitor the process by a variety of direct or indirect approaches [3] . One of the simplest ways to follow precipitation is by turbidity or nephelometry, but the results cannot be related directly to crystal mass or to particle size, shape or number. The initial rate of change of attenuance has been used as a quantitative measure of crystallization, without it being clear what the relative contribution of nucleation, growth and aggregation is to the overall result [4] [5] [6] [7] [8] . A recent study has shown that there is, empirically, a good correlation between this initial rate and the product of crystal number and crystal area, derived by image analysis of scanning microscopy pictures [6] . This suggests that, in the early stages, turbidity changes can be interpreted mainly in terms of an increase in volume or crystal growth, despite the likelihood of simultaneous nucleation and aggregation processes. This suggests, alongside the observation of second-order crystal growth rate kinetics in unseeded whole urine [10] , that the initial rate of turbidity change could be used to give an indirect estimate of the growth rate constant.
Before crystal growth can occur there must be nucleation, which under the supersaturation prevailing in the urinary tract will entail a heterogeneous mechanism. As an indicator of the propensity for nucleation, induction of crystallization has been widely used to quantify the metastable limit (ML), usually in terms of oxalate tolerance [8] [9] [10] [11] [12] [13] [14] [15] [16] ; this requires multiple oxalate concentrations to be tested and determination of the level that will initiate precipitation.
Here we explore the use of a multi-well plate turbidity method that has the potential to deliver meaningful kinetic data and objectively quantified oxalate tolerances. We have used 96-well plates, with a format of 24 oxalate concentrations each tested in quadruplicate. This allows us to attach statistical confidence limits to the determined initial rates of attenuance change, so that ML can be objectively defined in terms of the lowest oxalate concentration that brings about a rate significantly greater than the control. The 96-well plate format has been applied previously to estimate ML, using light microscopy to detect onset of crystallization after a 20 min incubation [16] . For oxalate concentrations above ML, we use the initial rate as a function of oxalate concentration to give an index that is related to the kinetic growth rate constant. The theoretical basis for this follows from the observations that the decay in calcium ion activity obeys second-order reaction kinetics in unseeded fresh whole urine when the initial oxalate concentration is well above ML [10] , and that the initial rate of change in turbidity is empirically related to the mass of crystalline product [6] .
In simple salt solutions, with a metastable supersaturation with respect to calcium oxalate and seeded with calcium oxalate crystals, the crystallization kinetics are expected to obey an equation of the form :
where S is the supersaturation ratio, t is time, K is the growth rate constant, a represents the seed characteristics (surface area, ' quality ', etc.) and n is the reaction order [17] . The supersaturation ratio is the ratio of the product of the free ion activities (denoted by oq) and the solubility product :
At a fixed temperature and pH, the solubility product will be constant (Sprod). Generally it has been found that, under practical conditions, the oxalate concentration (denoted by [Ox] ) can be substituted for activity and the rate order is 2 [18] . Using the program Equil2 [19] 
Baumann et al. [10] have shown that, in whole urine to which oxalate is added to induce spontaneous crystallization, the decay in calcium ion activity can also be fitted to second-order kinetics. This suggests that a finite number of heterogeneous nucleation sites are available, all of which become active at about the same supersaturation. These sites therefore account for parameter a in eqns. (1) and (3) . The decay in supersaturation (kds\dt) corresponds to the instantaneous growth rate and, assuming that the initial growth rate is proportional to the initial rate of change in turbidity (or attenuance, D), [6] then :
is the initial rate of change of attenuance, and
are the calcium and oxalate concentrations respectively at t l 0. Taking the logarithm of both sides gives :
So if a series of crystallization experiments is performed with fresh urine, using different concentrations of added oxalate but at a fixed pH, temperature and initial 
METHODS

Sample preparation
Artificial urine (AU) (at pH 6.0) was prepared with various [Ca] (each repeated five times) and with oxalate omitted. The concentrations of other components are given in [20] . Equil2 [19] was used to calculate the supersaturation of AU. Fresh human urine (HU) samples from healthy control subjects were also examined. Their pH and [Ca] values were measured immediately (atomic absorption spectroscopy), and 10 parts of the sample were diluted with 1 part of an appropriately concentrated solution of CaCl 
Turbidity measurements
A sample of 200 µl of urine was dispensed into each well of a new 96-well plate (tissue culture grade ; Falcon). The plate was placed in a plate reader (model MRX ; Dynatech Laboratories), which was programmed to shake the plate , and stopping when this condition is not met. When both of these reiterative procedures arrive at the same regression, or one has both a higher rate and a higher r 2 , then the ' best ' regression is unambiguous. If not, we use a series of selective criteria based on the absolute value of the differences between the regression in rate and r 2 . The figure shows two data sets (A and B), presenting four of the regression lines for each data set (offset for clarity). In set (A), regression 1 is selected, despite it not having the maximum r 2 , and in set (B) regression 22 is selected, even though it is not the maximum rate. 
Microscopy
For visualization, the plates were centrifuged at 250 g for 5 min, the medium was removed and the crystals were washed with water, re-centrifuged, the rinse removed and the plate allowed to dry at room temperature. Crystals were harvested in this way either at the end of conventional experiments in which the turbidity measurements were made, or 3 min after almost simultaneous addition of the different oxalate solutions. Crystals were viewed by light microscopy directly in the wells of the plate. For scanning electron microscopy, crystals were resuspended in a small volume of methanol and placed on to a cover slip. No attempt was made to quantify crystal numbers or sizes.
Data analysis
For our purposes we are only concerned with initial rates of change of attenuance (∆D\min) that are a good approximation to a straight line. Only those readings immediately preceding and for 12 min after each oxalate addition were considered. ∆D\min values were calculated by linear regression of the quadruplicate data. At high [Ox] ex , attenuance against time profiles were not always linear : a rapid rise was often followed by an approach to a plateau (due to supersaturation relief and aggregation). In order to obtain a non-subjective and automated estimate of the best initial (linear) rate, we separately calculated linear regressions for the first three time points following oxalate addition, and then the first four time points, etc., up to the first 24 time periods, and used an inspection algorithm designed to select the time period with the highest rate and the greatest amount of variation explained by the straight line (r#) (Figure 1 gives an example and further details). Results from this procedure corresponded with ' by eye ' selection of the best linear initial-rate period (tested with results from six urine samples ; 138 rate estimations). In some cases the rate was not linear over the first three time points following oxalate addition. This was checked for by calculating the rate from the difference between the time points immediately after and those immediately before oxalate addition, and comparing this with the rate calculated by regression over the first three time points after oxalate addition. If the former of these estimates exceeded the latter by more than 10 %, then it was concluded that the initial rate was too high to be quantified accurately. The oxalate tolerance was defined as the first (of at least two consecutive) [Ox] ex values that gave an initial rate whose lower 95 % confidence limit exceeded the upper 95 % confidence limit of the initial rate of the blank. ML is calculated as the oxalate tolerance plus endogenous [Ox] . Initial rates for [Ox] ex that exceeded the oxalate tolerance were corrected by subtracting any rate for the blank and plotted as ln (initial rate) against ln ([Ox] ex ), which gave approximately linear results. The ten highest [Ox] ex values (neglecting those that gave initial rates too high to be accurately measured) were used to calculate the best straight line. It is reasonable to ignore lower concentrations, as Baumann et al. [10] found that, with unseeded whole urine, calcium ion activity decay curves only fitted the rate equation when [Ox] ex values were well above ML. Analysis of these ln (∆D\min t = ! ) against ln ([Ox] ex ) plots was typically over ranges of [Ox] ex values of 1.1-3.6 mM, but would sometimes start as low as 0.6 mM or go up to 5 mM.
Statistical analysis
Linear regression to quadruplicate absorbance against time data can be performed in a number of different ways, each yielding the same rate but different error estimates. We used multiple linear regression to 
RESULTS
Visualization of crystals
Light and scanning microscopy ( Figures 2 and 3 ) of crystals showed increasing crystal density (no.\field) and increasing crystal size as [Ox] increased. At low numbers the crystals were mainly discrete, well formed calcium oxalate dihydrate or calcium oxalate monohydrate crystals. These crystals were mainly of a uniform size (single or twinned), with only rare aggregates or single crystals that were much larger than their neighbours. The density of apparent aggregates increased with crystal number, but it was often difficult to distinguish between crystals that had sedimented in close physical proximity and polycrystalline groups with a structural cohesion. As the crystal density increased, so too did the occurrence of a clustered needle morphology. These crystals were of comparable size to adjacent well formed single crystals, but were often seen in close association with each other, possibly as true aggregates.
ML determination
The ML for a particular measurement technique should represent the supersaturation at which nucleation and growth at the heterogeneous nucleation sites becomes detectable. When expressed as an oxalate concentration, it should therefore decrease with increasing [Ca] . This was the case for both AU and HU (Figure 4) . [Ca] l 3 mM ( ), 6 mM ($) or 9 mM (#). Each line represents one 96-well plate assay ; each point is the mean of four rate estimates p95 % confidence limits. When fitted to ML l α[Ca] −!.)" , over 50 % of the variation was explained (AU, r# l 0.88, P 0.001 ; HU, r# l 0.51, P 0.001) ; the factor α was significantly (P 0.05) different for this equation when fitted to the AU and HU data (AU, α l 1.88p0.12 ; HU, α l 1.35p0.14). A more direct demonstration of the expected constant value of ML (expressed as a supersaturation, calculated with Equil2) is shown in Figure 4 for the AU data. The ML (expressed as [Ox] ) for AU and HU therefore demonstrates the expected relationship with [Ca] and supersaturation. There was more variation in the results with HU, which, from fitting results over a wide range of [Ca] , tends to have a lower ML than a corresponding AU. In this system, the supersaturation ratio required for spontaneous precipitation was 13.6 for AU and approx. 9.9 for HU.
Validity of eqn. (5)
The plots of ln (∆D\min t = ! ) against ln ([Ox] ex ) gave good approximations to straight lines (AU, mean r# l 0.82, n l 30 ; HU, mean r# l 0.88, n l 80). Some representative data are shown in Figure 5 . The slopes of the fitted lines averaged 2.5 (AU) and 2.2 (HU). Considering integer values of the estimated slopes p95 % then, for AU, 28 out 30 slopes were consistent with a rate order of 2, while 74 out of 80 slopes for HU were consistent with n l 2. There was no significant relationship between the slope and [Ca] t = ! for AU (r# l 0.001, P l 0.86), but there was a slight negative relationship between slope and [Ca] t = ! for HU (r# l 0.09, P l 0.006 ; gradient l k0.08\mM Ca).
These results suggest that, under our experimental conditions, eqn. (5) is a reasonable approximation and that the intercept of the ln\ln plot will be related to the product of the growth rate constant and a factor describing the number and character of heterogeneous nucleators and [Ca] t = ! of the urine being tested. Hereafter, the anti-ln of this intercept will be referred to as a turbidity rate index (TRI). The error in estimation of the intercept for HU (n l 80) averaged 8.2 % (p95 %\TRIi100). Further support for eqn. (5) comes from plotting ln (TRI) against ln ([Ca] t = ! ) ( Figure 6 ), which gives a good approximation to a straight line for both AU and HU (r# l 0.995, P 0.001 and r# l 0.691, P 0.001 respectively). The confidence intervals for slopes of these lines overlap (AU, 2.79p0.27 ; HU, 2.31p0.35), while the intercepts are significantly different (AU, k11.92p0.44 ; HU, k8.98p0.53). The All specimens were adjusted to 6 mM Ca before analysis. The curve defines the relationship TRI l 0.035ie − 0.0024iOP , where OP is osmotic pressure (r 2 l 0.24, P l 0.01).
slopes of these lines are more consistent with a reaction order of 3 rather than 2. (e.g. 6 mM) . Considering those samples adjusted to 6 mM Ca (n l 29), we examined the relationship between turbidity results and urine concentration (measured as the osmotic pressure). There was no significant relationship between ML or the slope of the ln\ln plots of initial rate against [Ox] ex (r# l 0.001, P l 0.87 and r# l 0.05, P l 0.26 respectively). There was a significant negative relationship between osmotic pressure and TRI (exponential fit r# l 0.24, linear fit r# l 0.23 ; P l 0.01 ; Figure 7 ).
Effects of urine concentration
DISCUSSION
The 96-well plate format allows us to examine many different oxalate concentrations with sufficient replicates to assign statistical confidence to the results. Thus it is possible to give an objective criterion for oxalate tolerance, rather than relying on a looser definition, such as a ' demonstrable ' or ' dramatic ' change in absorbance [8, 11, 14] . Estimates of ML were related to [Ca] t = ! , as expected, and represent a characteristic supersaturation at which precipitation is initiated. Our interpretation of initial rates of attenuance, giving rise to a TRI, has a good theoretical foundation (despite the inherent oversimplifications), and is supported by the empirical evidence. Results with both AU and HU were consistent with second-order reaction kinetics (or third-order with respect to Ca free ion activity).
The ML for HU was significantly lower than that for AU when considered over the whole range of [Ca] t = !
. As the onset of nucleation is a threshold event, this probably reflects the presence of heteronucleation sites in native urine requiring a lower supersaturation to become active, rather than a greater number of such sites. The absence of any relationship between osmotic pressure and ML tends to confirm this interpretation. Figure 4 is of particular clinical significance, as it suggests an answer to a frequent question in stone research : ' why do normal people with supersaturated urine not form stones ? ' [21] . The supersaturation ratio required in urine from these healthy control subjects to initiate calcium oxalate crystallization was about 10, which is higher than would be encountered in normal urine unless inadequate fluid was being passed. Characteristics of the heterogeneous nucleators present in stone formers ' urine might bring about a lower ML than found for these healthy subjects, increasing the risk of crystalluria. Nevertheless, there is another valuable message to be drawn from Figure 4 . The shape of the ML against [Ca] curve is controlled by the chemistry relating to supersaturation. Therefore, if [Ca] can be kept below approx. 3 mM, an unphysiologically high [Ox] will be required for nucleation and crystal growth. Baumann et al. [10] have also pointed out the high [Ox] required for nucleation in whole urine.
Comparison of Figures 6(A) and 6(B) shows that the TRI was greater in HU than in AU (suggesting that Ka for HU is greater than Ka for AU). The main difference between these samples is the presence in HU of macromolecular growth inhibitors and nucleation promoters. Both of these types of crystallization modifiers will influence TRI. Growth inhibitors will decrease TRI through a reduction in the rate constant (K), and nucleation promoters will tend to increase TRI through parameter a (the heteronuclei surface area and characteristics). The overall increase in TRI suggests that the increase in a outweighs any decrease in K. This is essentially the same conclusion as we have drawn recently from another series of experiments comparing AU and HU, using a very different method in which nucleation and growth effects could be measured separately [20] . It should be recognized that our interpretation of differences in TRI between HU and AU is only valid under the particular experimental conditions used (i.e. very high supersaturation), but they do illustrate how one might interpret differences between different groups of HUs.
Although the basic principles of the method presented here are not new, the 96-well plate format has some particular advantages (many oxalate concentrations, tested repeatedly, in a short time). The new data analysis, leading to a TRI based on ln\ln plots of initial rate against [Ox] ex , builds on recent experimental findings [6, 10] , has a good theoretical basis and is well supported by our evidence. Microscopy of the crystals produced does suggest that some of our assumptions underpinning this interpretation are oversimplifications. The crystal density (no.\field) did not plateau at a fixed value, which might be expected if a (the seed parameter in the rate equation) were a true constant, and the light-scattering properties of crystals or aggregates with different morphologies will undoubtedly differ -although their cross-sectional surface area is always likely to be an important factor. Despite these reservations, the linearity of the data shown in Figures 5 and 6 gives us grounds for accepting our interpretation that the TRI is a workable approximation of Ka.
Comparison of AU and HU demonstrates the potential research value of this method. To be a clinically useful tool, any crystallization assay should fulfil a number of criteria : it should be simple, cheap, applicable to diluted or whole urine, give physico-chemically meaningful results, and be able to distinguish between stone-forming individuals and healthy control subjects. The method we have described fulfils most of these. To test its ability to distinguish between patients and controls, it would be important to perform the experiments from a common baseline by adjusting all urines to values of standard [Ca] t = ! and osmotic pressure before analysis. We now have evidence that, under these circumstances, the ML is significantly lower and the TRI significantly higher in stone-formers compared with control subjects [22] .
